NDRG1

Chr 8AR

N-myc downstream regulated 1

Also known as: CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL, NDR1, NMSL

The protein encoded by NDRG1 is a cytoplasmic stress-responsive protein that regulates cell growth and differentiation, maintains peripheral nerve myelin sheaths in Schwann cells, and is necessary for p53-mediated caspase activation and apoptosis. Autosomal recessive mutations cause Charcot-Marie-Tooth disease type 4D through a predicted gain-of-function mechanism. The protein functions in cell trafficking, vesicular recycling, and microtubule dynamics, with disruption of these processes leading to peripheral neuropathy.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
MultiplemechanismARLOEUF 0.581 OMIM phenotype
Clinical SummaryNDRG1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.
📋
ClinVar Variants
22 unique Pathogenic / Likely Pathogenic· 38 VUS of 200 total submissions
📖
GeneReview available — NDRG1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.58LOEUF
pLI 0.011
Z-score 3.14
OE 0.32 (0.190.58)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.65Z-score
OE missense 0.89 (0.790.99)
226 obs / 255.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.32 (0.190.58)
00.351.4
Missense OE0.89 (0.790.99)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 8 / 24.9Missense obs/exp: 226 / 255.3Syn Z: -0.66
DN
0.6358th %ile
GOF
0.6638th %ile
LOF
0.3842th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic9
VUS38
Likely Benign139
Benign1
13
Pathogenic
9
Likely Pathogenic
38
VUS
139
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
0
7
0
13
Likely Pathogenic
9
0
0
0
9
VUS
0
31
7
0
38
Likely Benign
1
3
94
41
139
Benign
0
0
1
0
1
Total163410941200

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NDRG1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →